FrancophonIA/ELRC3.0 huggingface dataset:
English: Eye ointments should be administered last.
Croatian: Masti za oko trebale bi se primjenjivati posljednje.
English: For storage conditions after first opening of the medicinal product, see section 6.3.
Croatian: Uvjete čuvanja nakon prvog otvaranja lijeka vidjeti u dijelu 6.3. 6.5 Vrsta i sadržaj spremnika
English: • Effects in the eye: Eye redness; fine deposits on the front of the eye and pain where the drops have been put in
Croatian: • Učinci na oko: crvenilo oka; sitan talog na prednjem dijelu oka i bol na mjestu gdje se ukapava
English: PHARMACEUTICAL FORM Eye drops, solution (eye drops).
Croatian: Kapi za oči, otopina (kapi za oči).
English: There are no or limited amount of data from the use of netarsudil in pregnant women.
Croatian: Nema podataka ili su podatci o primjeni netarsudila u trudnica ograničeni.
English: However, no effects are anticipated, since systemic exposure to netarsudil is negligible (see section 5.2).
Croatian: Međutim, ne očekuju se nikakvi učinci s obzirom na to da je sistemska izloženost netarsudilu zanemariva (vidjeti dio 5.2).
English: If you forget to use Rhokiinsa
Croatian: Ako ste zaboravili primijeniti lijek Rhokiinsa
English: What Rhokiinsa looks like and contents of the pack Rhokiinsa is a clear, liquid eye drop solution in a plastic bottle.
Croatian: Rhokiinsa kapi za oči su bistra otopina u plastičnoj bočici.
English: Systemic exposure to netarsudil following topical ocular administration has been shown to be negligible.
Croatian: 4.9 Predoziranje Sistemska izloženost netarsudilu nakon topikalne okularne primjene pokazala se zanemarivom.
English: Only use Rhokiinsa for your eyes (ocular use).
Croatian: Lijek Rhokiinsa se smije primjenjivati samo u oči (okularna primjena).
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains 200 micrograms netarsudil (as mesylate).
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedan ml otopine sadrži 200 mikrograma netarsudila (u obliku netarsudilmesilata).
English: If you stop using Rhokiinsa
Croatian: Ako prestanete primjenjivati lijek Rhokiinsa
English: Do not use more than one drop in the affected eye(s) once a day.
Croatian: Nemojte u oboljelo oko (oči) primjenjivati više od jedne kapi jednom dnevno.
English: IOP
Croatian: IOT
English: Benzalkonium chloride
Croatian: Sadržaj benzalkonijevog klorida
English: The study was designed to show non-inferiority of netarsudil when dosed once daily in the evening to timolol maleate 0.5% dosed twice daily in patients with a baseline IOP of >20 mmHg and <25 mmHg.
Croatian: Ispitivanje je osmišljeno kako bi pokazalo da netarsudil nije inferioran kada se primjenjuje jednom dnevno tijekom večeri u usporedbi s 0,5 %-tnim timolol maleatom koji se primjenjuje dva puta dnevno u bolesnika s početnom vrijednosti IOT-a > 20 mmHg i < 25 mmHg.
English: If you use more Rhokiinsa than you should
Croatian: Ako primijenite više lijeka Rhokiinsa nego što ste trebali Isperite oko toplom vodom.
English: The IOP reduction with netarsudil dosed once daily was non-inferior to the effect of timolol 0.5% dosed twice daily in patients with baseline IOP of <25 mmHg (Table 1).
Croatian: IOT-a koje se postiže primjenom netarsudila jednom dnevno nije bilo inferiorno učinku 0,5 %-tnog timolola koji se primjenjivao dva puta dnevno u bolesnika s početnom vrijednosti IOT-a < 25 mmHg (Tablica 1.).
English: • Effects in the eye: Increased fluid pressure inside the eye; inflammation of the coloured part of the eye (the iris); bulging of iris; growth of eyelashes; eyelid dryness; eye disease related to diabetes; excess folds of the conjunctiva; blindness; blurred, double and halo vision; cataracts; abnormal turning outward of the lower eyelid; small colored spots on the eye surface; eye dryness caused by inflammation of the glands of the eyelids; eye allergy; eyelid crusting; glassy eyes; loss of eyelashes; tiredness
Croatian: • Učinci na oko: povećan tlak tekućine u oku; upala obojenog dijela oka (šarenice); izbočena šarenica; rast trepavica; suhoća kapaka; bolesti oka vezane za dijabetes; višak nabora konjunktive (sluznice koja pokriva dio oka i unutarnju stranu kapka); sljepoća; zamagljen vid, dvoslike ili aureole oko izvora svjetlosti; mrena; neprirodno izvrtanje unutarnjeg dijela donjeg kapka prema van; male obojene točke na površini oka; suhoća oka uzrokovana upalom žlijezda kapaka; alergija oka; stvaranje krmelja na kapku; staklaste oči; gubitak trepavica; umor
English: Netarsudil belongs to a group of medicines called “Rho kinase inhibitors”, which work to reduce the amount of fluid inside the eye and so lower its pressure.
Croatian: „inhibitori Rho kinaze”, koji djeluju tako da smanjuju količinu tekućine u oku kako bi smanjili tlak u njemu.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Rhokiinsa in all subsets of the paediatric population for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Croatian: Europska agencija za lijekove izuzela je obvezu podnošenja rezultata ispitivanja lijeka Rhokiinsa u jednoj ili više podskupina pedijatrijske populacije za smanjenje povišenog intraokularnog tlaka u bolesnika s glaukomom otvorenog kuta ili okularnom hipertenzijom (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: Table 2: Mean IOP by visit: PP population with baseline IOP ≥25 and <30 mmHg Study Visit and Time Point
Croatian: Tablica 2.: Srednja vrijednost IOT-a po posjetu: Populacija koja je ispitivanje završila po protokolu (PP) s početnom vrijednosti IOT-a ≥ 25 i < 30 mmHg
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS BOTTLE LABEL
Croatian: PODATCI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE
English: It is unknown whether netarsudil/metabolites are excreted in human milk.
Croatian: Nije poznato izlučuju li se netarsudil ili njegovi metaboliti u majčino mlijeko.
English: • General side effects: Increased allergic symptoms; dizziness; blurred vision; nasal discomfort and pain; redness or itching of the skin; rash on skin; inflammation of the cartilage; picking of the skin
Croatian: • Opće nuspojave: povećani simptomi alergije; omaglica; zamagljen vid; nelagoda i bol u nosu; crvenilo i svrbež kože; osip na koži; upala hrskavice; površinska oštećenja kože
English: The following adverse reactions have been reported with netarsudil, dosed once daily.
Croatian: Prijavljene su sljedeće nuspojave za primjenu netarsudila, uz doziranje jednom dnevno.
English: Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.
Croatian: Upotreba kontaminiranih otopina može kao posljedicu imati ozbiljnu ozljedu oka i kasniji gubitak vida.
English: Efficacy was also investigated in patients with baseline IOP ≥25 mmHg and <30 mmHg.
Croatian: Djelotvornost je također ispitivana u bolesnika s početnom vrijednosti IOT-a ≥ 25 i < 30
English: decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Rhokiinsa therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Croatian: Rhokiinsa, uzimajući u obzir korist dojenja za dijete i korist terapije za ženu.
English: Due to netarsudil's vasodilating properties, other eye drops should be administered before.
Croatian: Zbog vazodilatacijskih svojstava netarsudila, potrebno je prvo primijeniti druge kapi za oči.
English: • Bring the bottle tip close to the eye. Do this in front of a mirror if it helps.
Croatian: Ako će vam biti lakše, učinite to pred zrcalom.
English: Uncommon dermatitis allergic, dermatitis contact, lichenification, petechiae Musculoskeletal and connective tissue disorders Uncommon polychondritis Injury, poisoning and procedural complications Uncommon excoriation 1 See Description of selected adverse reactions for further information
Croatian: Ozljede, trovanja i proceduralne komplikacije manje često ekskorijacija 1 Vidjeti Opis odabranih nuspojava za više pojedinosti
English: Do not store above 25
Croatian: Ne čuvati na temperaturi iznad 25 oC.
English: What Rhokiinsa contains - The active substance is netarsudil.
Croatian: Sadržaj pakiranja i druge informacije Što Rhokiinsa sadrži - Djelatna tvar je netarsudil.
English: How to store Rhokiinsa
Croatian: Kako primjenjivati lijek Rhokiinsa
English: With the exception of cornea verticillata (see above), no difference in the safety profile for Rhokiinsa has been observed between subjects aged <65 or ≥65 years.
Croatian: Uz iznimku cornea verticillata (vidjeti iznad), nisu primijećene razlike u sigurnosnom profilu za lijek
English: Each ml of solution contains 200 micrograms netarsudil (as mesylate).
Croatian: 1 ml otopine sadrži 200 mikrograma netarsudila (u obliku netarsudilmesilata).
English: How to use Rhokiinsa
Croatian: Kako čuvati lijek Rhokiinsa
English: Very common conjunctival hyperaemia1, cornea verticillata1, instillation site pain
Croatian: Poremećaji oka vrlo često konjunktivalna hiperemija cornea verticillata1, bol na mjestu ukapavanja često konjunktivalno krvarenje,
English: Rhokiinsa 200 micrograms/ml eye drops, solution netarsudil
Croatian: Rhokiinsa 200 mikrograma/ml kapi za oči, otopina netarsudil
English: Description of selected adverse reactions
Croatian: Opis odabranih nuspojava Konjunktivalna hiperemija
English: The recommended dosage is one drop in the affected eye(s) once daily in the evening.
Croatian: Primjena u odraslih, uključujući starije osobe Preporučena je doza jedna kap u oboljelo oko (oči), jednom dnevno navečer.
English: Common conjunctival haemorrhage, vision blurred, lacrimation increased, erythema of eyelid, eye pruritis, eye irritation, visual acuity reduced, eyelid oedema, punctate keratitis, conjunctival oedema, foreign body sensation in eyes, conjunctivitis, conjunctivitis allergic, photophobia, eyelid pruritus, eye pain, corneal opacity, dry eye, eye discharge,
Croatian: povećana lakrimacija, eritem kapka, svrbež oka, iritacija oka, smanjena oštrina vida, edem kapka, punktiformni keratitis, konjunktivalni edem,
English: What Rhokiinsa is and what it is used for What you need to know before you use Rhokiinsa How to use Rhokiinsa
Croatian: Što morate znati prije nego što počnete primjenjivati lijek Rhokiinsa
English: Cornea Verticillata
Croatian: distrofija rožnice,
English: The following side effects have been observed with Rhokiinsa:
Croatian: Kod primjene lijeka Rhokiinsa primijećene su sljedeće nuspojave;
English: • Effects in the eye: Infection or inflammation of the eye; dryness of the eye or small breaks in the film of liquid on the surface of the eye; eye discharge; itchy eyelids; clouding of the eye and vision may decrease somewhat; eye pain; feeling of grittiness or having something in the eye; general eye redness shortly after drops are put in; spots or patches of eye redness; eye inflammation caused by an allergic reaction or prominent blood vessels; eyes can become watery, sensitive to light; swelling around the eye; blurred vision
Croatian: osjećaj pijeska ili drugog stranog tijela u oku; općenito crvenilo oka nedugo nakon ukapavanja; točke ili tragovi crvenila oka; upala oka zbog alergijske reakcije ili istaknute krvne žile u oku; oči mogu suziti, biti osjetljive na svjetlo; oticanje oko oka; zamagljen vid
English: Sodium hydroxide (for pH-adjustment) Water for injections
Croatian: 6.1 Popis pomoćnih tvari benzalkonijev klorid manitol boratna kiselina natrijev hidroksid (za podešavanje pH vrijednosti) voda za injekcije
English: NAME OF THE MEDICINAL PRODUCT Rhokiinsa 200 micrograms/ml eye drops, solution.
Croatian: Rhokiinsa 200 mikrograma/ml kapi za oči, otopina.
English: Uncommon hypersensitivity
Croatian: Poremećaji imunološkog sustava manje često preosjetljivost
English: Table 1: Mean IOP by visit: PP population with baseline IOP <25 mmHg Study Visit and Time Point
Croatian: Tablica 1.: Srednja vrijednost IOT-a po posjetu: Populacija koja je ispitivanje završila po protokolu (PP)
English: Common headache Uncommon dizziness,
Croatian: osjećaj neugode na mjestu ukapavanja,
English: PHARMACEUTICAL FORM AND CONTENTS Eye drops, solution
Croatian: Kapi za oči, otopina
English: Treatment with Rhokiinsa should only be initiated by an ophthalmologist or a healthcare professional qualified in ophthalmology.
Croatian: 4.2 Doziranje i način primjene Liječenje lijekom Rhokiinsa smije započeti isključivo oftalmolog.
English: Eye disorders
Croatian: staklaste oči,
English: Respiratory, thoracic and mediastinal disorders Uncommon nasal discomfort, rhinalgia
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja manje često osjećaj neugode u nosu,
English: oC.
Croatian: mmHg.
English: Frequency Adverse reactions instillation site erythema, instillation site discomfort, instillation site pruritis, vital dye staining cornea present, intraocular pressure increased
Croatian: edem na mjestu ukapavanja, parestezija na mjestu ukapavanja, konjunktivalna obojenost, povećan omjer ekskavacije/papile vidnog živca, madaroza
English: Boric acid
Croatian: dijabetička retinopatija,
English: Elderly subjects
Croatian: Starije osobe
English: Your doctor will decide which strength is best for you.
Croatian: Liječnik će odlučiti koja je jačina za Vas najbolja.
English: The results in the control group were similar.
Croatian: Rezultati u kontrolnoj skupini bili su slični.
English: Data from six major trials are presented here.
Croatian: Tu su prikazani podaci iz šest velikih ispitivanja.
English: County Kerry Ireland
Croatian: County Kerry Irska
English: Improvement is usually seen within one week.
Croatian: Poboljšanje se obično vidi u roku od tjedan dana.
English: This leaflet was last revised in.
Croatian: Ova uputa je zadnji puta revidirana u .
English: • increased skin sensitivity (especially to hot and cold)
Croatian: • pojačana osjetljivost kože (osobito na toplinu i hladnoću)
English: Protopic with alcohol
Croatian: Protopic s alkoholom
English: • feeling of warmth
Croatian: • osjećaj topline
English: If you forget to apply the ointment at the scheduled time, do it as soon as you remember and then continue as before.
Croatian: Ako zaboravite primijeniti mast prema rasporedu, primjenite je čim se sjetite i potom nastavite kao i prije.
English: Median time to first DE 123 days
Croatian: Medijan vremena do prve EB 123 dana
English: These may include monitoring of vital signs and observation of clinical status.
Croatian: Te mjere mogu uključivati praćenje vitalnih znakova i promatranje kliničkog stanja.
English: Repeated dose toxicity and local tolerance
Croatian: Toksičnost ponavljanih doza i lokalna podnošljivost
English: The average total body clearance is approximately 2.25 l/h.
Croatian: Prosječni ukupni tjelesni klirens iznosi približno 2,25 l/h.
English: In addition, ask your doctor for advice on other appropriate sun protection methods.
Croatian: Osim toga, potražite savjet liječnika o drugim prikladnim načinima zaštite od sunca.
English: Do not try to induce vomiting.
Croatian: Nemojte pokušati izazvati povraćanje.
English: Treatment duration was for up to three weeks.
Croatian: Liječenje je trajalo do tri tjedna.
English: Other medicines, cosmetics and Protopic
Croatian: Drugi lijekovi, kozmetički proizvodi i Protopic
English: Protopic can be used for short-term and intermittent long-term treatment.
Croatian: Protopic se može uporabiti za kratkotrajno i za intermitentno dugotrajno liječenje.
English: Specific studies have not been conducted in older people.
Croatian: Nisu provedena posebna ispitivanja u starijih osoba.
English: The response rates at month 6 were comparable to the 3-month results.
Croatian: Stope odgovora u 6. mjesecu bile su usporedive s rezultatima u 3. mjesecu.
English: Rosacea* Lentigo*
Croatian: rozacea* lentigo*
English: Systemic exposure increases with increasing treatment areas.
Croatian: Sistemska izloženost povećava se s povećanjem područja liječenja.
English: Children, 2-15 years
Croatian: Djeca, 2-15 godina
English: Therefore it should not be used in this age group.
Croatian: Stoga se ne smije primjenjivati u toj dobnoj skupini.
English: Date of first authorisation: 28 February 2002 Date of latest renewal: 20 November 2006
Croatian: Datum posljednje obnove odobrenja: 20. studenoga 2006.
English: What Protopic is and what it is used for
Croatian: Što je Protopic i za što se koristi
English: Thereafter, patients are considered suitable for maintenance treatment (see below).
Croatian: Nakon toga se bolesnici smatraju pogodnima za terapiju održavanja (vidjeti niže).
English: Generally, improvement is seen within one week of starting treatment.
Croatian: Općenito se poboljšanje vidi u roku od tjedan dana od početka liječenja.
English: In the presence of these infections, the balance of risks and benefits associated with Protopic use should be evaluated.
Croatian: U prisutnosti tih infekcija, potrebno je procijeniti ravnotežu rizika i koristi povezanih s primjenom Protopic masti.
English: Pharmacotherapeutic group: Other dermatologicals, ATC code: D11AH01
Croatian: Farmakoterapijska skupina: drugi dermatologici, ATK oznaka: D11AH01
English: However, the clinical experience available in this patient population has not shown the necessity for any dosage adjustment.
Croatian: Međutim, dostupno kliničko iskustvo u ove populacije bolesnika nije pokazalo da je potrebna prilagodba doziranja.
English: The majority of these cases were related to infections (skin, respiratory tract, tooth) and resolved with appropriate antibiotic therapy.
Croatian: Većina tih slučajeva bila je povezana s infekcijama (kože, dišnog sustava, zuba) i riješila se odgovarajućom antibiotskom terapijom.
English: Adults, ≥16 years
Croatian: Odrasli, ≥ 16 godina
English: The incidence and nature of most adverse events were similar in the two treatment groups.
Croatian: Incidencija i priroda većine nuspojava bile su slične u obje terapijske skupine.
English: • Avoid using the ointment inside your nose or mouth or in your eyes.
Croatian: • Izbjegavajte primjenu masti u nos, usta ili oči.
English: In addition, there was no evidence of loss of efficacy throughout the duration of the clinical trial.
Croatian: Osim toga, nije bilo dokaza gubitka djelotvornosti tijekom trajanja kliničkog ispitivanja.
English: If you do not see any improvement after two weeks, see your doctor about other possible treatments.
Croatian: Ako ne vidite poboljšanje nakon dva tjedna, posjetite liječnika zbog drugih mogućih načina liječenja.
English: • If you have infected lesions.
Croatian: • ako imate inficirane lezije.
English: 4.6 Fertility, Pregnancy and lactation
Croatian: 4.6 Plodnost, trudnoća i dojenje
English: Occlusive dressings are not recommended.
Croatian: Okluzivni povoji se ne preporučuju.
English: Treatment should be started twice a day for up to three weeks.
Croatian: Potrebno je započeti liječenje dvaput na dan do najviše tri tjedna.
English: § lower values = greater improvement
Croatian: § niže vrijednosti = veće poboljšanje
English: Ophthalmic Herpes Infection*
Croatian: oftalmološke herpes infekcije*
English: Contents of the pack and other information What Protopic contains
Croatian: Sadržaj pakiranja i druge informacije Što Protopic sadrži
English: Talk to your doctor before using Protopic:
Croatian: Obratite se svom liječniku prije nego primijenite Protopic:
English: • If you notice any change to the appearance of your skin, please inform your physician.
Croatian: • ako primijetite promjenu izgleda kože, molimo obavijestite o tome svog liječnika.
English: At the first signs of recurrence (flares) of the disease symptoms, treatment should be re-initiated.
Croatian: Kod prvih znakova povratka (rasplamsavanja) simptoma bolesti potrebno je ponovno uvesti liječenje.
English: If you are prescribed light therapy, inform your doctor that you are using Protopic as it is not recommended to use Protopic and light therapy at the same time.
Croatian: Ako Vam je propisana svjetlosna terapija, obavijestite svog liječnika da primjenjujete Protopic jer se ne preporučuje primjenjivati Protopic i svjetlosnu terapiju u isto vrijeme.
English: Median time to first DE requiring substantial intervention
Croatian: Medijan vremena do prve EB koja je zahtijevala znatnu intervenciju
English: Studies in animals have shown reproductive toxicity following systemic administration (see section 5.3).
Croatian: Ispitivanja na životinjama pokazala su reproduktivnu toksičnost nakon sistemske primjene (vidjeti dio 5.3).
English: Protopic treatment should begin at the first appearance of signs and symptoms.
Croatian: Liječenje Protopic mašću treba započeti kod pojave prvih znakova i simptoma.
English: It is unclear whether the effect of tacrolimus is due to systemic immunosuppression or a local effect.
Croatian: Nije jasno je li učinak takrolimusa posljedica sistemske imunosupresije ili lokalnog učinka.
English: Response rate of ≥ 60%
Croatian: Stopa odgovora s ≥ 60%
English: Systemic carcinogenicity studies in mice (18 months) and rats (24 months) revealed no carcinogenic potential of tacrolimus.
Croatian: Ispitivanja sustavne kancerogenosti u miševa (18 mjeseci) i štakora (24 mjeseca) nisu otkrila kancerogeni potencijal takrolimusa.
English: What Protopic looks like and contents of the pack
Croatian: Kako Protopic izgleda i sadržaj pakiranja
English: • Avoid exposing the skin to long periods of sunlight or artificial sunlight such as tanning beds.
Croatian: • Izbjegavajte dugotrajno izlaganje kože suncu ili umjetnom sunčevom svjetlu kao u solarijima.
English: (0.03%) had blood concentrations <1.0 ng/ml.
Croatian: (0,03%) imali su koncentracije u krvi < 1,0 ng/ml.
English: Please consult your doctor.
Croatian: Potražite savjet liječnika.
English: Protopic ointment should not be used during pregnancy unless clearly necessary.
Croatian: Protopic mast se ne smije primjenjivati tijekom trudnoće osim ako za time postoji jasna potreba.
English: These skin conditions may increase systemic absorption of tacrolimus.
Croatian: Ta kožna stanja mogu povećati sistemsku apsorpciju takrolimusa.
English: It is supplied in tubes containing 10, 30 or 60 grams of ointment.
Croatian: Isporučuje se u tubama koje sadrže 10, 30 ili 60 grama masti.
English: As systemic exposure is low with tacrolimus ointment, the high binding of tacrolimus (>98.8%) to plasma proteins is considered not to be clinically relevant.
Croatian: Budući da je sistemska izloženost takrolimusu iz masti niska, smatra se da visoka stopa vezanja takrolimusa za proteine plazme (> 98,8%) nije klinički značajna.
English: Frequencies are defined as very common (≥1/10), common (≥1/100 to <1/10) and uncommon (≥1/1,000 to <1/100).
Croatian: Učestalosti su definirane kao vrlo česte (≥ 1/10), česte (≥ 1/100 i < 1/10) i manje česte (≥ 1/1 000 i < 1/100).
English: Slightly lower body weight gain in females was the only systemic change observed in micropigs at high ointment concentrations (3%).
Croatian: Nešto manji dobitak na tjelesnoj težini u ženki bila je jedina sistemska promjena opažena u patuljastih svinja pri visokim koncentracijama takrolimusa u masti (3%).
English: Following repeated topical application of the ointment the average half-life of tacrolimus was estimated to be 75 hours for adults and 65 hours for children.
Croatian: Nakon ponovne topikalne primjene masti, procijenjeno je da prosječan poluvijek takrolimusa iznosi 75 sati u odraslih i 65 sati u djece.
English: improvement in mEASI (Primary Endpoint)§§
Croatian: poboljšanja na mEASI (primarni ishod)§§
English: • The effect of treatment with Protopic on the developing immune system in children, especially the young, has not been established.
Croatian: • Učinak liječenja Protopic mašću na razvoj imunološkog sustava u djece, osobito male, nije ustanovljen.
English: LEO Pharma A/S Industriparken 55 2750 Ballerup Denmark
Croatian: LEO Pharma A/S Industriparken 55 2750 Ballerup Danska
English: Physicians should advise patients on appropriate sun protection methods, such as minimisation of the time in the sun, use of a sunscreen product and covering of the skin with appropriate clothing.
Croatian: Liječnici trebaju savjetovati bolesnicima odgovarajuće metode za zaštitu od sunca, na primjer, da što manje vremena provode na suncu, koriste pripravke za zaštitu od sunca i pokrivaju kožu odgovarajućom odjećom.